Insiders · Profile

LAROSA JOSEPH J

EVP General Counsel and Secret at Regeneron Pharmaceuticals. Filing since 16 Mar 2015. CIK 0001238303

Company
Date
Role
Action
Shares
Amount
Of holding
11 Jul 2024
EVP General Counsel and Secret
Sold on a plan
1,866
$2.03M
4.7%
21 May 2024
EVP General Counsel and Secret
Sold on a plan
1,865
$1.86M
5.1%
26 Feb 2024
EVP General Counsel and Secret
Sold at will
1,000
$990.00K
2.7%
22 Feb 2024
EVP General Counsel and Secret
Sold at will
1,000
$967.65K
2.6%
7 Feb 2024
EVP General Counsel and Secret
Sold at will
1,000
$950.00K
2.5%
7 Apr 2022
EVP General Counsel and Secret
Sold, plan not stated
5,114
$3.69M
23.2%
1 Apr 2022
EVP General Counsel and Secret
Sold, plan not stated
5,114
$3.53M
18.9%
23 Aug 2021
EVP General Counsel and Secret
Sold, plan not stated
3,425
$2.27M
20.6%
6 Jul 2021
EVP General Counsel and Secret
Sold, plan not stated
3,398
$1.97M
20.5%
31 Aug 2020
EVP General Counsel and Secret
Sold, plan not stated
4,672
$2.87M
24.4%
15 May 2020
EVP General Counsel and Secret
Sold, plan not stated
8,380
$4.79M
36.7%
20 Apr 2020
EVP General Counsel and Secret
Sold, plan not stated
5,300
$3.01M
26.9%
17 Apr 2020
EVP General Counsel and Secret
Sold, plan not stated
2,267
$1.26M
13.6%
15 Apr 2020
EVP General Counsel and Secret
Sold, plan not stated
2,262
$1.17M
13.5%
2 Apr 2020
EVP General Counsel and Secret
Sold, plan not stated
6,797
$3.33M
32.0%
16 Mar 2015
SVP General Counsel and Secret
Sold, plan not stated
18,311
$8.24M
64.7%
16 decisions on file.